NewslettersExtracellular Matrix NewsImmune Regulation News Blockade of TGF-β and PD-L1 by Bintrafusp Alfa Promotes Survival in Preclinical Ovarian Cancer Models by Promoting T Effector and NK Cell Responses By lbeveridge - April 15, 2024 0 The authors tested whether coordinated blockade of TGF-β and PD-L1 with bintrafusp alfa could provoke anti-tumour immune responses in preclinical high-grade serous ovarian cancer models. [British Journal Of Cancer] Full Article